Substituted and bridged tetrahydropyridines useful as calcium entry
申请人:Merck & Co., Inc.
公开号:US04579851A1
公开(公告)日:1986-04-01
Substituted dihydropyridines and substituted and bridged tetrahydropyridines are disclosed which are useful as calcium entry blockers.
本发明揭示了用作钙通道阻滞剂的取代二氢吡啶和取代和桥联四氢吡啶。
Substituted and bridged pyridines useful as pharmaceutical agents
申请人:Merck & Co., Inc.
公开号:EP0163238B1
公开(公告)日:1991-07-24
BALDWIN J. J.; CLAREMON D. A.; LUMMA P. K.; MCCLURE D. E.; ROSENTHAL S. A+, J. MED. CHEM., 30,(1987) N 4, 690-695
作者:BALDWIN J. J.、 CLAREMON D. A.、 LUMMA P. K.、 MCCLURE D. E.、 ROSENTHAL S. A+
DOI:——
日期:——
US4579851A
申请人:——
公开号:US4579851A
公开(公告)日:1986-04-01
Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11-dicarboxylates as calcium entry antagonists: new conformationally restrained analogs of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformation
作者:John J. Baldwin、David A. Claremon、Patricia K. Lumma、David E. McClure、Seth A. Rosenthal、Raymond J. Winquist、Elizabeth P. Faison、Gregory J. Kaczorowski、Mayme J. Trumble、Graham M. Smith
DOI:10.1021/jm00387a019
日期:1987.4
The pharmacological activity of rigid analogues of 1,4-dihydropyridine calcium entry antagonists 9-16 is demonstrated by dose-dependent inhibition of the calcium contraction in depolarized rat aortic strips and by a [3H]nitrendipine binding assay in using cardiac sarcolemmal membranes. From the results, a model is proposed as the receptor-bound conformation of the dihydropyridine calcium entry antagonists.